supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
supplement:
Aspartic Acid
drug:
Carbendazim
Research Papers that Mention the Interaction
“10623 Background: Single agent weekly docetaxel D ) is an active agent in the treatment of MBC with response rates of 29% - 53%.”
Toxicity and outcome data in a phase II study of weekly docetaxel in combination with erlotinib in recurrent and/or metastatic breast cancer (MBC).
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback